Skip to main content
Clinical Trials/NCT02021539
NCT02021539
Terminated
Not Applicable

The Prognostic Value of Cervical Elastography for Identifying Patients at Risk for Preterm Delivery

Centre Hospitalier Universitaire de Nīmes1 site in 1 country66 target enrollmentFebruary 2014

Overview

Phase
Not Applicable
Intervention
Cervical ultrasound +elastography 1
Conditions
Obstetric Labor
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
66
Locations
1
Primary Endpoint
Ultrasound measure of the cervix (mm)
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

The hypothesis tested is that the physical changes associated with cervical ripening result in a detectable decrease in rigidity. The main objective of this study is therefore to determine whether the measured elastographic rigidity of cervical tissues in addition to cervix size can be used to predict delivery within the next 48 hours (creation of a prognostic score).

Detailed Description

The secondary objectives of this study are: A-To compare the prognostic qualities of elastography scores and fetal fibronectin measurements for predicting the risk of delivery in the next 48 hours. B-To evaluate the economic impact of introducing elastographic and fibronectin measures during consultatios for obstetric emergencies from the point of vue of the French social security system and the hospital. C-To evaluate the prognostic value of elastographic measurements in the subgroup twins. D-To study elastography variation according to patient outcomes. E-Evaluate the reproducibility of intra-and inter-rater elastographic measurements.

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
December 2016
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient must have given her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • Pregnant women presenting between the 24th and 34th week of pregnancy, with uterine contractions associated with cervical changes objectified by ultrasound examination of the cervix (5-25mm)
  • Single or multiple pregnancy

Exclusion Criteria

  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient has lost her water (placental rupture)
  • History of cervical surgery

Arms & Interventions

The study population

The study population consists of pregnant women presenting between the 24th and 34th week of pregnancy, with uterine contractions associated with cervical changes objectified by ultrasound examination of the cervix (5-25mm) who consult for obstetric emergencies (both single or multiple pregnancies can be included). Intervention : Cervical ultrasound +elastography 1 Intervention : Vaginal fibronectin measurement Intervention : Tocolytic treatment for 2 hours Intervention : Cervical ultrasound +elastography 2

Intervention: Cervical ultrasound +elastography 1

The study population

The study population consists of pregnant women presenting between the 24th and 34th week of pregnancy, with uterine contractions associated with cervical changes objectified by ultrasound examination of the cervix (5-25mm) who consult for obstetric emergencies (both single or multiple pregnancies can be included). Intervention : Cervical ultrasound +elastography 1 Intervention : Vaginal fibronectin measurement Intervention : Tocolytic treatment for 2 hours Intervention : Cervical ultrasound +elastography 2

Intervention: Vaginal fibronectin measurement

The study population

The study population consists of pregnant women presenting between the 24th and 34th week of pregnancy, with uterine contractions associated with cervical changes objectified by ultrasound examination of the cervix (5-25mm) who consult for obstetric emergencies (both single or multiple pregnancies can be included). Intervention : Cervical ultrasound +elastography 1 Intervention : Vaginal fibronectin measurement Intervention : Tocolytic treatment for 2 hours Intervention : Cervical ultrasound +elastography 2

Intervention: Tocolytic treatment for 2 hours

The study population

The study population consists of pregnant women presenting between the 24th and 34th week of pregnancy, with uterine contractions associated with cervical changes objectified by ultrasound examination of the cervix (5-25mm) who consult for obstetric emergencies (both single or multiple pregnancies can be included). Intervention : Cervical ultrasound +elastography 1 Intervention : Vaginal fibronectin measurement Intervention : Tocolytic treatment for 2 hours Intervention : Cervical ultrasound +elastography 2

Intervention: Cervical ultrasound +elastography 2

Outcomes

Primary Outcomes

Ultrasound measure of the cervix (mm)

Time Frame: Day 2

Elastography score

Time Frame: Day 0 or within 12 hours

The score ranges from 0 to 10.

Secondary Outcomes

  • Elastography score(after 2 hours of tocolytic treatment on day 0)
  • Avoidable hospital costs(Hospital discharge (expected maximum of 20 days))
  • Was the first ultrasound/elastography carried out while the patient was already on tocolytics? yes/no(Day 0 or 1)
  • Vaginal fetal fibronectin(Day 2)

Study Sites (1)

Loading locations...

Similar Trials